Ronald B. Moss

940 total citations
39 papers, 729 citations indexed

About

Ronald B. Moss is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Ronald B. Moss has authored 39 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Virology, 18 papers in Immunology and 16 papers in Infectious Diseases. Recurrent topics in Ronald B. Moss's work include HIV Research and Treatment (27 papers), Immune Cell Function and Interaction (16 papers) and HIV/AIDS drug development and treatment (12 papers). Ronald B. Moss is often cited by papers focused on HIV Research and Treatment (27 papers), Immune Cell Function and Interaction (16 papers) and HIV/AIDS drug development and treatment (12 papers). Ronald B. Moss collaborates with scholars based in United States, Canada and Thailand. Ronald B. Moss's co-authors include Dennis J. Carlo, Mark R. Wallace, Fred C. Jensen, Fang Fang, Wieslawa Giermakowska, Roy T. Steigbigel, Richard T. Davey, Steven P. Richieri, Georgia Theofan and Alfredo Garzino‐Demo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Ronald B. Moss

39 papers receiving 691 citations

Peers

Ronald B. Moss
Kristen V. Khanna United States
Kim Sannerud United States
D. Eichenlaub Germany
R. Pristerà Italy
Lisa LaFranco-Scheuch United States
Filippo Speranza Italy
Julie H. McArthur United States
Donald R. Skillman United States
Ronald Schut United States
Carolina Gutiérrez Spain
Kristen V. Khanna United States
Ronald B. Moss
Citations per year, relative to Ronald B. Moss Ronald B. Moss (= 1×) peers Kristen V. Khanna

Countries citing papers authored by Ronald B. Moss

Since Specialization
Citations

This map shows the geographic impact of Ronald B. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald B. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald B. Moss more than expected).

Fields of papers citing papers by Ronald B. Moss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald B. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald B. Moss. The network helps show where Ronald B. Moss may publish in the future.

Co-authorship network of co-authors of Ronald B. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald B. Moss. A scholar is included among the top collaborators of Ronald B. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald B. Moss. Ronald B. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Moss, Ronald B. & Dennis J. Carlo. (2019). Higher doses of naloxone are needed in the synthetic opioid era. Substance Abuse Treatment Prevention and Policy. 14(1). 6–6. 110 indexed citations
4.
5.
Moss, Ronald B., et al.. (2018). Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector. Annals of Allergy Asthma & Immunology. 120(5). 540–541. 4 indexed citations
6.
Moss, Ronald B., Richard T. Davey, Roy T. Steigbigel, & Fang Fang. (2010). Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. Journal of Antimicrobial Chemotherapy. 65(6). 1086–1093. 55 indexed citations
7.
Triana‐Baltzer, Gallen, Larisa V. Gubareva, Alexander Klimov, et al.. (2009). Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein. PLoS ONE. 4(11). e7838–e7838. 62 indexed citations
8.
Moss, Ronald B., Carolyn Brandt, Wieslawa Giermakowska, et al.. (2003). HIV-specific immunity during structured antiviral drug treatment interruption. Vaccine. 21(11-12). 1066–1071. 14 indexed citations
9.
Banaszczyk, Mariusz, et al.. (2002). Propofol Phosphate, a Water-Soluble Propofol Prodrug:In Vivo Evaluation. Anesthesia & Analgesia. 95(5). 1285–1292. 38 indexed citations
10.
Moss, Ronald B., et al.. (2000). HIV-Specific CD4 + and CD8 + Immune Responses Are Generated with a gp120-Depleted, Whole-Killed HIV-1 Immunogen with CpG Immunostimulatory Sequences of DNA. Journal of Interferon & Cytokine Research. 20(12). 1131–1137. 15 indexed citations
11.
Maino, Vernon C., Maria Suni, Susan B. Wormsley, et al.. (2000). Enhancement of HIV Type 1 Antigen-Specific CD4 + T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen. AIDS Research and Human Retroviruses. 16(6). 539–547. 37 indexed citations
12.
Moss, Ronald B., Fred C. Jensen, & Dennis J. Carlo. (2000). Insights into HIV-Specific Immune Function: Implications for Therapy and Prevention in the New Millennium. Clinical Immunology. 95(2). 79–84. 4 indexed citations
13.
Maino, Vernon C., Maria Suni, Susan B. Wormsley, et al.. (2000). Enhancement of HIV Type 1 Antigen-Specific CD4 + T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen. AIDS Research and Human Retroviruses. 16(18). 2065–2066. 8 indexed citations
14.
15.
Moss, Ronald B., Mark R. Wallace, Wieslawa Giermakowska, et al.. (1999). Phenotypic Analysis of Human Immunodeficiency Virus (HIV) Type 1 Cell‐Mediated Immune Responses after Treatment with an HIV‐1 Immunogen. The Journal of Infectious Diseases. 180(3). 641–648. 25 indexed citations
16.
Churdboonchart, Vina, Ronald B. Moss, Worachart Sirawaraporn, et al.. (1998). Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in Thailand. AIDS. 12(12). 1521–1527. 12 indexed citations
17.
Lanza, Paola, Ronald B. Moss, Wieslawa Giermakowska, et al.. (1998). Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination. Vaccine. 16(7). 727–731. 4 indexed citations
18.
Moss, Ronald B., Richard Trauger, Wieslawa Giermakowska, et al.. (1997). Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). 343–350. 27 indexed citations
19.
Moss, Ronald B., Steven P. Richieri, F. Ferré, et al.. (1997). HIV-1-Specific Functional ImmuneMeasurements as Markers ofDisease Progression. Journal of Biomedical Science. 4(4). 127–131. 1 indexed citations
20.
Wallace, Mark R., Ronald B. Moss, H. James Beecham, et al.. (1996). Early Clinical Markers and CD4 Percentage in Subjects with Human Immunodeficiency Virus Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(4). 358–362. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen V. Khanna Breakdown of academic impact, for papers by Kim Sannerud Breakdown of academic impact, for papers by D. Eichenlaub Breakdown of academic impact, for papers by R. Pristerà Breakdown of academic impact, for papers by Lisa LaFranco-Scheuch Breakdown of academic impact, for papers by Filippo Speranza Breakdown of academic impact, for papers by Julie H. McArthur Breakdown of academic impact, for papers by Donald R. Skillman Breakdown of academic impact, for papers by Ronald Schut Breakdown of academic impact, for papers by Carolina Gutiérrez
Rankless by CCL
2026